Cytosorbents Corporation
CTSO
$1.10
-$0.06-5.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.28M | 5.69M | 8.46M | 8.61M | 14.13M |
| Total Receivables | 7.32M | 6.63M | 7.82M | 6.77M | 6.06M |
| Inventory | 2.73M | 3.25M | 4.32M | 3.74M | 3.38M |
| Prepaid Expenses | 3.27M | 1.03M | 1.36M | 880.40K | 1.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.00M | -- | -- | -- | -- |
| Total Current Assets | 21.60M | 16.60M | 21.96M | 19.99M | 25.40M |
|
|
|||||
| Total Current Assets | 21.60M | 16.60M | 21.96M | 19.99M | 25.40M |
| Net Property, Plant & Equipment | 20.51M | 20.92M | 21.21M | 21.67M | 22.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.75M | -- | -- | -- | 3.91M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.51M | 10.29M | 10.26M | 5.40M | 1.54M |
| Total Assets | 47.37M | 47.80M | 53.43M | 47.07M | 52.96M |
|
|
|||||
| Total Accounts Payable | 3.34M | 2.34M | 3.05M | 2.40M | 3.80M |
| Total Accrued Expenses | 4.75M | 4.82M | 5.58M | 6.54M | 4.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 452.70K | 432.00K | 412.10K | 2.89M | 2.87M |
| Total Finance Division Other Current Liabilities | 1.28M | 837.60K | 1.30M | 1.60M | 2.37M |
| Total Other Current Liabilities | 1.28M | 837.60K | 1.30M | 1.60M | 2.37M |
| Total Current Liabilities | 9.82M | 8.43M | 10.34M | 13.42M | 14.04M |
|
|
|||||
| Total Current Liabilities | 9.82M | 8.43M | 10.34M | 13.42M | 14.04M |
| Long-Term Debt | 14.00M | 13.81M | 13.67M | 1.93M | 2.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.44M | 12.57M | 12.68M | 12.79M | 12.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 36.26M | 34.80M | 36.69M | 28.14M | 29.48M |
|
|
|||||
| Common Stock & APIC | 310.86M | 308.50M | 307.57M | 306.04M | 306.24M |
| Retained Earnings | -304.01M | -295.34M | -293.01M | -288.86M | -283.29M |
| Treasury Stock & Other | 4.25M | -156.90K | 2.17M | 1.75M | 529.30K |
| Total Common Equity | 11.11M | 13.00M | 16.74M | 18.93M | 23.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.11M | 13.00M | 16.74M | 18.93M | 23.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.11M | 13.00M | 16.74M | 18.93M | 23.48M |
|
|
|||||